Second Sight Medical Products announced market entry into South Korea, implanting two patients with the company’s Argus II Retinal Prosthesis System in Seoul. The implants were facilitated by the country’s exclusive distribution partner, Kisantech Co., Ltd. A second patient in Taiwan also received the company’s Argus II. This surgical procedure was facilitated by Orient Europharma Co., Ltd., Second Sight’s exclusive distribution partner for Taiwan.
“These implants represent important milestones in the company’s efforts to expand our footprint in Asia. With our entry into South Korea, and a second implant now performed in Taiwan, we are continuing our mission to bring Argus II to even more blind individuals around the world. We look forward to treating more patients throughout Asia in the coming months,” Will McGuire, Chief Executive Officer of Second Sight, said in a company news release.
The two implants in South Korea were performed by Young Hee Yoon, MD, Professor, Department of Ophthalmology, Asan Medical Center, in May 2017 and June 2017 at the Asan Medical Center in Seoul in 54- and 56-year old patients with Retinitis Pigmentosa. The second implant in Taiwan was performed in April 2017 by Dr. Shi-Jen Chen at Taipei Veterans General Hospital in a 55-year old patient with retinal degeneration. As previously announced, the first Argus II in Taiwan was implanted by Dr. Yih-Shiou Hwang at Chang Gung Memorial Hospital in a 40-year old patient with retinal degeneration.